Shortages of medicines in a psychiatric hospital in Cyprus

[1] Davie, M. (2015). Doing more for mental health. Archives of Disease in Childhood—Education & Practice Edition, 101(2), 77–81. doi:10.1136/archdischild-2015-308344 DavieM. 2015 Doing more for mental health Archives of Disease in Childhood—Education & Practice Edition 101 2 77 81 10.1136/archdischild-2015-308344 Open DOISearch in Google Scholar

[2] McLaughlin, M., Kotis, D., Thomson, K., Harrison, M., Fennessy, G., Postelnick, M., & Scheetz, M. H. (2013). Effects on patient care caused by drug shortages: A survey. Journal of Managed Care Pharmacy, 19(9), 783–788. doi:10.18553/jmcp.2013.19.9.783 McLaughlinM. KotisD. ThomsonK. HarrisonM. FennessyG. PostelnickM. ScheetzM. H. 2013 Effects on patient care caused by drug shortages: A survey Journal of Managed Care Pharmacy 19 9 783 788 10.18553/jmcp.2013.19.9.783 Open DOISearch in Google Scholar

[3] Sunkel, C., & Viljoen, M. (2017). Shortage of psychiatric medications in South Africa. The Lancet Psychiatry, 4(1), 15–16. doi:10.1016/s2215-0366(16)30422-9 SunkelC. ViljoenM. 2017 Shortage of psychiatric medications in South Africa The Lancet Psychiatry 4 1 15 16 10.1016/s2215-0366(16)30422-9 Open DOISearch in Google Scholar

[4] Omorodion, J. O., Algahtani, R. M., Zocchi, M. S., Fox, E. R., Pines, J. M., & Kaminski, H. J. (2017). Shortage of generic neurologic therapeutics. Neurology, 89(24), 2431–2437. doi:10.1212/wnl.0000000000004737. OmorodionJ. O. AlgahtaniR. M. ZocchiM. S. FoxE. R. PinesJ. M. KaminskiH. J. 2017 Shortage of generic neurologic therapeutics Neurology 89 24 2431 2437 10.1212/wnl.0000000000004737 29142086 Open DOISearch in Google Scholar

[5] Yazed Sulaiman Al-Ruthia, Wael Mansy, Mohammad Barasin, Yazeed Mohammad Ghawaa, Mohammed Al Sultan, Mohammad A. AlsenaidySolaiman Alhawas a, Sultan AlGhadeer (2017). Shortage of psychotropic medications in community pharmacies in Saudi Arabia: Causes and solutions Saudi Pharmaceutical Journal, 25, 744–749 Al-RuthiaYazed Sulaiman MansyWael BarasinMohammad GhawaaYazeed Mohammad Al SultanMohammed AlsenaidyMohammad A. AlhawasSolaiman a, AlGhadeerSultan 2017 Shortage of psychotropic medications in community pharmacies in Saudi Arabia: Causes and solutions Saudi Pharmaceutical Journal 25 744 749 10.1016/j.jsps.2016.10.013550673528725147 Search in Google Scholar

[6] Desmarais, J. E., Beauclair, L., Margolese, H. C. (2011). Switching from brand-name to generic psychotropic medications: a literature review. CNS Neurosci Ther. 17(6): 750–60. DesmaraisJ. E. BeauclairL. MargoleseH. C. 2011 Switching from brand-name to generic psychotropic medications: a literature review CNS Neurosci Ther. 17 6 750 60 10.1111/j.1755-5949.2010.00210.x649385321114789 Search in Google Scholar

[7] Kluznik. J. C., Walbek, N. H., Farnsworth, M. G., et al. (2001). Clinical effects of a randomized switch of patients from clozaril to generic clozapine. J Clin Psychiatry, 62 (Suppl 5): 14–7 KluznikJ. C. WalbekN. H. FarnsworthM. G. 2001 Clinical effects of a randomized switch of patients from clozaril to generic clozapine J Clin Psychiatry 62 Suppl 5 14 7 Search in Google Scholar

[8] Petrou, P., Vandoros, S. (2015). Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access or quality of treatment. Health Policy, 119(5), 563–568. PetrouP. VandorosS. 2015 Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access or quality of treatment Health Policy 119 5 563 568 10.1016/j.healthpol.2015.03.00425837234 Search in Google Scholar

[9] Petrou, P., (2021) The 2019 introduction of the new National Healthcare System in Cyprus. Health Policy 125 (3), 284–289 PetrouP. 2021 The 2019 introduction of the new National Healthcare System in Cyprus Health Policy 125 3 284 289 10.1016/j.healthpol.2020.12.01833516561 Search in Google Scholar

[10] https://www.eahp.eu/practice-and-policy/medicines-shortages https://www.eahp.eu/practice-and-policy/medicines-shortages Search in Google Scholar

[11] Al Ruthia, Y. S., Al Kofide, H., Al Ajmi, R., Balkhi, B., Alghamdi, A., Al Nasser, A., Alathbah, A. (2017). Drug shortages in large hospitals in Riyadh: a cross-sectional study. Annals of Saudi medicine, 37(5), 375–385. doi:10.5144/0256-4947.2017.375 Al RuthiaY. S. Al KofideH. Al AjmiR. BalkhiB. AlghamdiA. Al NasserA. AlathbahA. 2017 Drug shortages in large hospitals in Riyadh: a cross-sectional study Annals of Saudi medicine 37 5 375 385 10.5144/0256-4947.2017.375 607419128988252 Open DOISearch in Google Scholar

[12] Gray, A., Manasse, H. R. (2012). Shortage of medicines: a complex global challenge. Bulletin of the World Health Organization 154–154A. GrayA. ManasseH. R. 2012 Shortage of medicines: a complex global challenge Bulletin of the World Health Organization 154 154A 10.2471/BLT.11.101303331420322461706 Search in Google Scholar

[13] Bochenek, T., Abilova, V., Alkan, A., Asanin, B., de Miguel Beriain, I., Besovic, Z., Vella Bonanno, P., Bucsics, A., Davidescu, M., De Weerdt, E., Duborija-Kovacevic, N., Fürst, J., Gaga, M., Gailīte, E., Gulbinovič, J., Gürpınar, E. U., Hankó, B., Hargaden, V., Hotvedt, T.A., Hoxha, I., Huys, I., Inotai, A., Jakupi, A., Jenzer, H., Joppi, R., Laius, O., Lenormand, M-C., Makridaki, D., Malaj, A., Margus, K., Marković-Peković, V., Miljković, N., de Miranda, J. L., Primožič, S., Rajinac, D., Schwartz, D. G., Šebesta, R., Simoens, S., Slaby, J., Sović-Brkičić, L,, Tesar, T., Tzimis, L., Warmińska, E. and Godman, B. (2018). Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries. Front. Pharmacol. 8, 942. doi: 10.3389/fphar.2017.00942 BochenekT. AbilovaV. AlkanA. AsaninB. de Miguel BeriainI. BesovicZ. Vella BonannoP. BucsicsA. DavidescuM. De WeerdtE. Duborija-KovacevicN. FürstJ. GagaM. GailīteE. GulbinovičJ. GürpınarE. U. HankóB. HargadenV. HotvedtT.A. HoxhaI. HuysI. InotaiA. JakupiA. JenzerH. JoppiR. LaiusO. LenormandM-C. MakridakiD. MalajA. MargusK. Marković-PekovićV. MiljkovićN. de MirandaJ. L. PrimožičS. RajinacD. SchwartzD. G. ŠebestaR. SimoensS. SlabyJ. Sović-BrkičićL. TesarT. TzimisL. WarmińskaE. GodmanB. 2018 Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries Front. Pharmacol. 8 942 10.3389/fphar.2017.00942 577907229403372 Open DOISearch in Google Scholar

[14] Finnish Medicines Agency. Helsinki: Finnish Medicines Agency; 2019. www.fimea.fi/web/en/supervision/mandatory_reserve_supplies. Accessed 28 March 2019. Finnish Medicines Agency Helsinki: Finnish Medicines Agency 2019 www.fimea.fi/web/en/supervision/mandatory_reserve_supplies. Accessed 28 March 2019. Search in Google Scholar

[15] Weaver, J. M. (2010). Why are there so many drug shortages? Anesth Prog. 57, 89–90 WeaverJ. M. 2010 Why are there so many drug shortages? Anesth Prog 57 89 90 10.2344/0003-3006-57.3.89331527220843222 Search in Google Scholar

[15] Petrou, P., Vandoros, S. (2018). Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it? Health Policy 122, 75–80 PetrouP. VandorosS. 2018 Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it? Health Policy 122 75 80 10.1016/j.healthpol.2017.11.00429274916 Search in Google Scholar